ROY F CHEMALY to Antifungal Agents
This is a "connection" page, showing publications ROY F CHEMALY has written about Antifungal Agents.
Connection Strength
0.280
-
Update on infection control practices in cancer hospitals. CA Cancer J Clin. 2018 09; 68(5):340-355.
Score: 0.106
-
Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study. Clin Ther. 2007 Sep; 29(9):1980-6.
Score: 0.050
-
Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis. 2005 Dec; 5(12):775-85.
Score: 0.044
-
A case of zygomycosis and invasive candidiasis involving the epiglottis and tongue in an immunocompromised patient. Scand J Infect Dis. 2002; 34(2):149-51.
Score: 0.034
-
Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis. PLoS One. 2015; 10(11):e0139851.
Score: 0.022
-
Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. Eur J Clin Microbiol Infect Dis. 2008 May; 27(5):343-7.
Score: 0.013
-
Fungal osteoarticular infections in patients treated at a comprehensive cancer centre: a 10-year retrospective review. Clin Microbiol Infect. 2006 Jul; 12(7):621-6.
Score: 0.012